Achillion Pharmaceuticals Inc.


UBS and JMP Securities Downgrade Achillion Pharmaceuticals, Inc. (ACHN) Following Johnson & Johnson (JNJ) Deal

Biotechnology company Achillion Pharmaceuticals, Inc. (NASDAQ:ACHN) fell about 10% in trading on Wednesday, May 20 following the company’s announcement that it licensed its …

Cowen Shines Light on Achillion Pharmaceuticals, Inc. (ACHN) Partnership with Johnson & Johnson

Cowen analyst Phil Nadeau weighed in today with a few observations on Achillion Pharmaceuticals, Inc. (NASDAQ:ACHN), following the company’s announcement that it has partnered its …

Stock Update (NASDAQ:ACHN): Achillion Pharmaceuticals, Inc. Enters Into Worldwide Collaboration for Hepatitis C With Janssen

Achillion Pharmaceuticals, Inc. (NASDAQ:ACHN) announced today that it has entered into a worldwide license and collaboration arrangement with Janssen Pharmaceuticals, Inc.

Why Gilead Sciences, Inc. (GILD) Should Buy Out Achillion Pharmaceuticals, Inc. (ACHN)

Achillion Pharmaceuticals, Inc. (NASDAQ:ACHN) Gilead Sciences, Inc.

Tuesday Pre-Market Insights: MannKind Corporation (MNKD), Achillion Pharmaceuticals, Inc. (ACHN), Etsy Inc (ETSY), Opko Health Inc. (OPK)

MannKind Corporation (NASDAQ:MNKD) shares increased approximately 4.5% in pre-market trading to $4.

Achillion Pharmaceuticals, Inc. (ACHN) Stock Is On A Breakout Climb, Will Gains Last?

Achillion Pharmaceuticals, Inc. (NASDAQ:ACHN) Achillion Pharmaceuticals stock is soaring in the market today.

Stay Ahead of Everyone Else

Get The Latest Stock News Alerts